DBS system

DBS system

[¦dē¦bē ′es ‚sis·təm]
References in periodicals archive ?
About 40 patients treated with the Vercise DBS System demonstrated a 63% improvement in motor function at 52 weeks from baseline as measured by the Unified Parkinson's Disease Rating Scale III, as well as improvements in quality of life and medication usage.
Since FDA approval of MRI instructions for use in 2002, patients with Medtronic DBS could receive head scans at a low radiofrequency (RF) power limit and the DBS system had to be turned off before the MRI scan.
Boston Scientific said Intelect Medical's technology could be combined with its own Vercise DBS System, which is designed to deliver electrical signals to specific areas within the brain.
The components of the DBS system include a neurostimulator that connects to two leads that are implanted in the anterior nucleus of the thalamus.
Medtronic remains the only company with a commercially available DBS system currently approved by the United States Food and Drug Administration (FDA) and in Europe for management of symptoms of movement disorders, including Parkinson's disease, essential tremor and dystonia1, and severe, treatment-resistant obsessive-compulsive disorder2 not adequately controlled by medications.
Jude Medical aims to empower physicians to more accurately deliver stimulation with a DBS system.
The company said that the Vercise DBS System is the first and only commercially available DBS system to incorporate multiple independent current control, which is designed to selectively stimulate targeted areas in the brain.
Jude Medical Infinity DBS system, which will be available in two sizes, is the only upgradeable DBS system available to patients battling movement disorders.
The ActivaA PC+S DBS system delivers Medtronic DBS therapy while simultaneously sensing and recording electrical signals in key areas of the brain, using sensing technology and an adjustable stimulation algorithm.
The company's Vercise DBS System is the first and only commercially available DBS system to incorporate multiple independent current control to selectively stimulate targeted areas in the brain.
All of the studies being presented used the Medtronic DBS system to stimulate a target within the brain called the ventral anterior limb of the internal capsule/ventral striatum (VC/VS), which is a central node in the neural circuits that regulate mood and anxiety.